ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026)
ClearPoint Neuro recorded quarterly Income from Continuing Operations of 9552000.0 in Q1 2026, down 22.68% quarter-over-quarter from 7786000.0 in Q4 2025, and down 58.51% year-over-year from 23024140.8 in Q1 2025.
ClearPoint Neuro's Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 9552000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 58.51% year-over-year to 9552000.0; the TTM figure through Mar 2026 stood at 29066000.0 (down 39.78% YoY), while the FY2025 annual figure was 25540000.0, down 35.03% from the prior year.
- Income from Continuing Operations came in at 9552000.0 for Q1 2026 at ClearPoint Neuro, down from 7786000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3795000.0 in Q3 2022 to a low of 9552000.0 in Q1 2026.
- A 5-year average of 5469470.59 and a median of 4974000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations sank 66.03% in 2023 and surged 38.19% in 2024, its largest moves.
- ClearPoint Neuro's Income from Continuing Operations stood at 4469000.0 in 2022, then decreased by 5.3% to 4706000.0 in 2023, then declined by 14.45% to 5386000.0 in 2024, then tumbled by 44.56% to 7786000.0 in 2025, then dropped by 22.68% to 9552000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 9552000.0, 7786000.0, and 5891000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -9.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.55 Mn |
| Dec 31, 2025 | -7.79 Mn |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -5.84 Mn |
| Mar 31, 2025 | -6.03 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.15 Mn |
| Dec 31, 2023 | -4.71 Mn |
| Sep 30, 2023 | -4.90 Mn |
| Jun 30, 2023 | -7.13 Mn |
| Mar 31, 2023 | -5.71 Mn |
| Dec 31, 2022 | -4.47 Mn |
| Sep 30, 2022 | -3.80 Mn |
| Jun 30, 2022 | -4.30 Mn |
| Mar 31, 2022 | -3.97 Mn |
| Dec 31, 2021 | -4.15 Mn |
| Sep 30, 2021 | -4.04 Mn |
| Jun 30, 2021 | -3.65 Mn |
| Mar 31, 2021 | -2.51 Mn |
| Dec 31, 2020 | -2.47 Mn |
| Sep 30, 2020 | -1.47 Mn |
| Jun 30, 2020 | -1.67 Mn |
| Mar 31, 2020 | -2.05 Mn |
| Dec 31, 2019 | -1.65 Mn |
| Sep 30, 2019 | -1.12 Mn |
| Jun 30, 2019 | -1.55 Mn |
| Mar 31, 2019 | -1.23 Mn |
| Dec 31, 2018 | -1.22 Mn |
| Sep 30, 2018 | -1.45 Mn |
| Jun 30, 2018 | -1.88 Mn |
| Mar 31, 2018 | -1.67 Mn |
| Sep 30, 2016 | -1.95 Mn |
| Jun 30, 2016 | -2.30 Mn |
| Mar 31, 2016 | -2.27 Mn |
| Sep 30, 2015 | -2.24 Mn |
| Jun 30, 2015 | -2.99 Mn |
| Mar 31, 2015 | -3.25 Mn |
| Dec 31, 2014 | -2.97 Mn |
| Sep 30, 2014 | -2.90 Mn |
| Jun 30, 2014 | -2.49 Mn |
| Mar 31, 2014 | 2.04 Mn |
| Dec 31, 2013 | -3.06 Mn |
| Sep 30, 2013 | -1.98 Mn |
| Jun 30, 2013 | -2.30 Mn |
| Mar 31, 2013 | -2.72 Mn |
| Dec 31, 2012 | -564,523.00 |
| Sep 30, 2012 | -1.10 Mn |
| Jun 30, 2012 | -574,184.00 |
| Mar 31, 2012 | -3.48 Mn |
| Dec 31, 2011 | -1.96 Mn |
| Sep 30, 2011 | -2.14 Mn |
| Jun 30, 2011 | -2.07 Mn |
| Mar 31, 2011 | -2.25 Mn |